Your browser doesn't support javascript.
loading
Immune Checkpoint Inhibitors in Lung Cancer - An Unheralded Opportunity?
Marshall, R; Popple, A; Kordbacheh, T; Honeychurch, J; Faivre-Finn, C; Illidge, T.
Afiliación
  • Marshall R; Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Popple A; Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Kordbacheh T; Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Honeychurch J; Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Faivre-Finn C; Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK.
  • Illidge T; Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK. Electronic address: tmi@manchester.ac.uk.
Clin Oncol (R Coll Radiol) ; 29(4): 207-217, 2017 04.
Article en En | MEDLINE | ID: mdl-28063623

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Inmunoterapia / Neoplasias Pulmonares / Anticuerpos Monoclonales / Antineoplásicos Límite: Humans Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Inmunoterapia / Neoplasias Pulmonares / Anticuerpos Monoclonales / Antineoplásicos Límite: Humans Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido